This month, we take a behind-the-scenes look at guideline development, debate the length of anticoagulation for cancer-associated thrombosis, and report on the latest hematologic research from the American Society of Clinical Oncology annual meeting and the International Society on Thrombosis and Haemostasis 2015 Congress.
This month, we uncover the potential pitfalls of precision medicine, report on the latest hematologic research from the American Society of Clinical Oncology annual meeting and European Hematology Association Congress, and more.
This month, we take an in-depth look at the work that hematology advocates are doing, the latest research from Blood, and the latest hematology/oncology news.
This issue features a look at new tactics for fighting the cancer drug pricing bloat, a debate on fludarabine in CLL, a report from ASH’s Sickle Cell Disease Summit, and more.
This issue features a look at the ACA’s out-of-pocket limit, reports from the IOM’s Pediatric Oncology Workshop, tips for improving your presentations, and more.
This issue features a debate of rituximab versus splenectomy in ITP patients, a look at novel oral anticoagulants taking warfarin’s place, mentoring advice from a fellowship program director, and more.
This issue features ABIM's update to MOC, the endocrinologist's perspective on diabetes management, an analysis of the Choosing Wisely program, and more.
A special edition featuring drug updates from the 2014 ASH Annual Meeting.
This issue features breakthrough research from the 2014 ASH Annual Meeting, a look at changing definitions of value, a debate over transplant in AML patients, and more.
This issue features an update from the ASH Choosing Wisely Task Force, a look at the first wave of Sunshine Act data, a debate over radiation therapy in Hodgkin lymphoma, and more.